tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ZVRA Stock Latest News

Zevra Therapeutics to be added to Nasdaq Biotechnology Index
The FlyZevra Therapeutics to be added to Nasdaq Biotechnology Index
4d ago
ZVRA
Zevra Therapeutics Restructures to Focus on Rare Diseases
PremiumCompany Announcements
Zevra Therapeutics Restructures to Focus on Rare Diseases
15d ago
8K
ZVRA
Zevra Therapeutics announces departure of CDO Christal Mickle, CSO Sven Guenther
PremiumThe Fly
Zevra Therapeutics announces departure of CDO Christal Mickle, CSO Sven Guenther
15d ago
ZVRA
Zevra Therapeutics Launches MIPLYFFA for Niemann-Pick Disease
PremiumCompany Announcements
Zevra Therapeutics Launches MIPLYFFA for Niemann-Pick Disease
29d ago
8K
ZVRA
Zevra Therapeutics announces U.S. commercial availability of MIPLYFFA
PremiumThe Fly
Zevra Therapeutics announces U.S. commercial availability of MIPLYFFA
30d ago
ZVRA
Zevra Therapeutics price target lowered to $23 from $25 at Canaccord
PremiumThe FlyZevra Therapeutics price target lowered to $23 from $25 at Canaccord
1M ago
ZVRA
Zevra Therapeutics’ Transformative Third Quarter 2024
Premium
Company Announcements
Zevra Therapeutics’ Transformative Third Quarter 2024
1M ago
ZVRA
Zevra Therapeutics reports Q3 EPS (69c), consensus (42c)
Premium
The Fly
Zevra Therapeutics reports Q3 EPS (69c), consensus (42c)
1M ago
ZVRA
William Blair pharmaceuticals analysts hold analyst/industry conference call
PremiumThe Fly
William Blair pharmaceuticals analysts hold analyst/industry conference call
1M ago
ZVRA
ZVRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ZVRA Upcoming Earnings Report: What to Expect?
1M ago
ZVRA
Zevra Therapeutics, NUCDF launch check ammonia campaign
PremiumThe Fly
Zevra Therapeutics, NUCDF launch check ammonia campaign
2M ago
ZVRA
Zevra Therapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
Zevra Therapeutics initiated with a Buy at Guggenheim
3M ago
ZVRA
Zevra Therapeutics price target raised to $21 from $19 at Roth MKM
PremiumThe FlyZevra Therapeutics price target raised to $21 from $19 at Roth MKM
3M ago
ZVRA
Zevra Therapeutics price target raised to $25 from $18 at Maxim
Premium
The Fly
Zevra Therapeutics price target raised to $25 from $18 at Maxim
3M ago
ZVRA
Zevra Therapeutics initiated with an Outperform at JMP Securities
Premium
The Fly
Zevra Therapeutics initiated with an Outperform at JMP Securities
3M ago
ZVRA
Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC
PremiumThe Fly
Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC
3M ago
XOMA
ZVRA
Zevra Therapeutics’ MIPLYFFA Wins FDA Approval for NPC
PremiumCompany Announcements
Zevra Therapeutics’ MIPLYFFA Wins FDA Approval for NPC
3M ago
8K
ZVRA
Zevra Therapeutics Inc trading resumes
PremiumThe Fly
Zevra Therapeutics Inc trading resumes
3M ago
ZVRA
Zevra Therapeutics price target raised to $20 from $18 at H.C. Wainwright
PremiumThe Fly
Zevra Therapeutics price target raised to $20 from $18 at H.C. Wainwright
3M ago
ZVRA
Zevra Therapeutics receives FDA approval for Miplyffa
PremiumThe FlyZevra Therapeutics receives FDA approval for Miplyffa
3M ago
ZVRA
FDA approves Zevra’s Miplyffa, first treatment for Neimann-Pick disease, type C
Premium
The Fly
FDA approves Zevra’s Miplyffa, first treatment for Neimann-Pick disease, type C
3M ago
ZVRA
Zevra Therapeutics Inc trading halted, news pending
Premium
The Fly
Zevra Therapeutics Inc trading halted, news pending
3M ago
ZVRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >